Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Substantially Amorphous Form Of An Anticancer Agent
Abstract: SUBSTANTIALLY AMORPHOUS FORM OF AN ANTICANCER AGENT AND PROCESS FOR PREPARATION THEREOF The present invention provides a novel substantially amorphous form of an anticancer agent, namely, 4[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[{4-(3-pyridnyl)-2-pyrimidinly}amino] phenyl] benzamide methanesulfonate, commonly known as imatinib mesylate and process for preparation thereof.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
24 November 2003
Publication Number
34/2005
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
SUN PHARMACEUTICAL INDUSTRIES LTD
ACME PLAZA,
ANDHERI-KURLA ROAD,
ANDHERI (E),
MUMBAI-400059
Inventors
1. HETALKUMAR VIRENDRABHAI PATEL
SUN PHARMA ADVANCED RESEARCH CENTRE,
AKOTA ROAD,
AKOTA, BARODA 390020
2. JITENDRA GOPALDAS DIPCHANDANI
SUN PHARMA ADVANCED RESEARCH CENTRE,
AKOTA ROAD,
AKOTA, BARODA 390020
3. RAJA JYOTIR JANI
SUN PHARMA ADVANCED RESEARCH CENTRE,
AKOTA ROAD,
AKOTA, BARODA 390020
4. THENNATI RAJAMANNAR
SUN PHARMA ADVANCED RESEARCH CENTRE,
AKOTA ROAD,
AKOTA, BARODA 390020
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 1209-mum-2003-abstract(3-11-2004).pdf | 2018-08-08 |
| 1 | 1209-mum-2003-form 2(title page)-(provisional)-(24-11-2003).pdf | 2003-11-24 |
| 2 | 1209-mum-2003-claims(complete)-(3-11-2004).pdf | 2018-08-08 |
| 2 | 1209-mum-2003-form 2(provisional)-(24-11-2003).pdf | 2003-11-24 |
| 3 | 1209-mum-2003-form 1(24-11-2003).pdf | 2003-11-24 |
| 3 | 1209-mum-2003-correspondence(ipo)-(18-2-2011).pdf | 2018-08-08 |
| 4 | 1209-mum-2003-description(provisional)-(24-11-2003).pdf | 2003-11-24 |
| 4 | 1209-mum-2003-description(complete)-(3-11-2004).pdf | 2018-08-08 |
| 5 | 1209-mum-2003-drawing(3-11-2004).pdf | 2018-08-08 |
| 5 | 1209-mum-2003-correspondence(30-10-2007).pdf | 2007-10-30 |
| 6 | 1209-mum-2003-form 18(31-10-2007).pdf | 2007-10-31 |
| 6 | 1209-mum-2003-form 1(1-12-2003).pdf | 2018-08-08 |
| 7 | 1209-mum-2003-form 2(complete)-(3-11-2004).pdf | 2018-08-08 |
| 7 | 1209-mum-2003-correspondence(17-12-2007).pdf | 2007-12-17 |
| 8 | 1209-MUM-2003_EXAMREPORT.pdf | 2018-08-08 |
| 8 | 1209-mum-2003-form 2(title page)-(complete)-(3-11-2004).pdf | 2018-08-08 |
| 9 | 1209-mum-2003-form 3(3-11-2004).pdf | 2018-08-08 |
| 9 | 1209-mum-2003-form 5(3-11-2004).pdf | 2018-08-08 |
| 10 | 1209-mum-2003-form 3(3-11-2004).pdf | 2018-08-08 |
| 10 | 1209-mum-2003-form 5(3-11-2004).pdf | 2018-08-08 |
| 11 | 1209-mum-2003-form 2(title page)-(complete)-(3-11-2004).pdf | 2018-08-08 |
| 11 | 1209-MUM-2003_EXAMREPORT.pdf | 2018-08-08 |
| 12 | 1209-mum-2003-correspondence(17-12-2007).pdf | 2007-12-17 |
| 12 | 1209-mum-2003-form 2(complete)-(3-11-2004).pdf | 2018-08-08 |
| 13 | 1209-mum-2003-form 1(1-12-2003).pdf | 2018-08-08 |
| 13 | 1209-mum-2003-form 18(31-10-2007).pdf | 2007-10-31 |
| 14 | 1209-mum-2003-correspondence(30-10-2007).pdf | 2007-10-30 |
| 14 | 1209-mum-2003-drawing(3-11-2004).pdf | 2018-08-08 |
| 15 | 1209-mum-2003-description(complete)-(3-11-2004).pdf | 2018-08-08 |
| 15 | 1209-mum-2003-description(provisional)-(24-11-2003).pdf | 2003-11-24 |
| 16 | 1209-mum-2003-correspondence(ipo)-(18-2-2011).pdf | 2018-08-08 |
| 16 | 1209-mum-2003-form 1(24-11-2003).pdf | 2003-11-24 |
| 17 | 1209-mum-2003-claims(complete)-(3-11-2004).pdf | 2018-08-08 |
| 17 | 1209-mum-2003-form 2(provisional)-(24-11-2003).pdf | 2003-11-24 |
| 18 | 1209-mum-2003-form 2(title page)-(provisional)-(24-11-2003).pdf | 2003-11-24 |
| 18 | 1209-mum-2003-abstract(3-11-2004).pdf | 2018-08-08 |